Neuren Pharmaceuticals | NEU - Operating Profit

Stock Price
13.44
Daily Change
0.73 5.74%
Monthly
-22.89%
Yearly
-5.35%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD5.45M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Clinuvel Pharmaceuticals AUD 39.05M 21.49M Jun/2024
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Genetic Signatures AUD -15.16M 7.8M Dec/2024
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
Medical Developments International AUD -480K 662K Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Organon & Co USD 388M 62M Sep/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025